EvanS.DellonMD
Gastroenterology • Chapel Hill, NCAdvanced Endoscopic Interventional
Assistant Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Dr. Dellon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Cir
Ste 313
Chapel Hill, NC 27517Phone+1 919-843-7200Fax+1 919-843-7136
Education & Training
University of North Carolina HospitalsFellowship, Gastroenterology, 2004 - 2007
Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2002
Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
NC State Medical License 2004 - 2025
MA State Medical License 2001 - 2004- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Start of enrollment: 2008 Jun 01
- Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) Start of enrollment: 2009 Oct 01
- Registry for Eosinophilic Gastrointestinal Disorders (REGID) Start of enrollment: 2012 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsEosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and ManagementErin C. Steinbach, Michelle L. Hernandez, Evan S. Dellon
The Journal of Allergy and Clinical Immunology. in Practice. 2018-09-01 - 14 citationsEosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis.Evan S Dellon
The American Journal of Gastroenterology. 2022-05-01 - 81 citationsIncreasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data...Robert D. Pesek, Craig C. Reed, Amanda B. Muir, Patricia C. Fulkerson, Calies Menard-Katcher
The American Journal of Gastroenterology. 2019-06-01
Journal Articles
- Anti–Siglec-8 Antibody for Eosinophilic Gastritis and DuodenitisEvan S Dellon, Kathryn A Peterson, Gary W Falk, Nirmala Gonsalves, Michael Vaezi, Adam C Bledsoe, Alan T Chang, Ikuo Hirano, The New England Journal of Medicine
- RPC4046 in Patients with Eosinophilic EsophagitisEvan S Dellon, Ikuo Hirano, Clinical Gastroenterology and Hepatology
Authored Content
- RPC4046 in Patients with Eosinophilic EsophagitisMarch 2020
Press Mentions
Novel Drug Improved Symptoms in Eosinophilic EsophagitisOctober 30th, 2024- Efficacy and Pharmacokinetic Results from Ongoing Dose Escalation in RESOLVE, a Phase 1b/2a Study of EP-104GI (Extended-Release Fluticasone Propionate Intra-Esophageal Injection) for Eosinophilic EsophagitisOctober 29th, 2024
- VIDEO: Mepolizumab for EoE Does Not Yield ‘Prominent Symptom Improvement’ After 6 MonthsMay 11th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
